Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
RNA Interference01:23

RNA Interference

26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Comprehensive Analysis of the Agreement and Performance of Variant Annotation Programs in Equine Genomes.

Genes·2026
Same author

Towards a Comprehensive Screening Approach for Detecting Gene Doping in Racehorses and Sport Horses by Targeting Common and Intrinsic Plasmid Sequences.

Drug testing and analysis·2026
Same author

Functional minigenome system reveals polymerase features of swine orthopneumovirus.

Journal of virology·2026
Same author

In vitro liquid-liquid phase separation induced by respiratory syncytial virus proteins and RNA.

Science advances·2026
Same author

Learning inherent genetic patterns and trait associations with deep generative models for discrete genotype simulation.

GigaScience·2026
Same author

A spike-binding protein as a versatile tool to detect and inhibit transmissible gastroenteritis virus.

Virology·2026
Same journal

A DNA-guided prokaryotic argonaute enables programmable RNA cleavage for sequencing and quality control of <i>in vitro</i>-transcribed RNAs.

Molecular therapy. Nucleic acids·2026
Same journal

Enhanced γ-globin reactivation and sickle cell correction through a repressor-to-activator motif switch in the <i>HBG1/2</i> promoters.

Molecular therapy. Nucleic acids·2026
Same journal

Optimizing twin prime editing components for scalable genome editing and therapy in spinocerebellar ataxia type 3.

Molecular therapy. Nucleic acids·2026
Same journal

Enhancing protein expression in humans through codon optimization with transformer and contrastive learning.

Molecular therapy. Nucleic acids·2026
Same journal

Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome.

Molecular therapy. Nucleic acids·2026
Same journal

Meta-analysis of adverse events in clinical studies with antisense oligonucleotide therapies.

Molecular therapy. Nucleic acids·2026
查看所有相关文章

相关实验视频

Updated: Sep 14, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

针对SARS-CoV-2核体基因的反感性寡核酸降低了仓鼠中的病毒标位.

Christopher Fitzpatrick1,2, Nicolas Meunier2, Sophie Lepoder3

  • 1Université Paris-Saclay, AgroParisTech, INRAE, GABI UMR1313, 78350 Jouy-en-Josas, France.

Molecular therapy. Nucleic acids
|July 21, 2025
PubMed
概括
此摘要是机器生成的。

针对SARS-CoV-2核体RNA的反感性寡核化物 (ASOs) 显示出作为一种新型抗病毒策略的前景. ASO-N1在降低病毒载量和改善受感染仓鼠的临床症状方面表现出显著的有效性.

关键词:
在 COVID-19 疫情中,MT: 寡核酸是一种原核酸.在RNA疗法中使用RNA疗法.治疗方法和应用方法这是一种抗病毒药物.它们是morpholinos,它们是morpholinos.核体中的核体.有协同效应的效应.

更多相关视频

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.2K

相关实验视频

Last Updated: Sep 14, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.2K

科学领域:

  • 病毒学和分子生物学
  • 抗病毒疗法 抗病毒疗法
  • 氧核酸治疗药物 治疗药物

背景情况:

  • 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 导致正在进行的COVID-19大流行.
  • 新出现的SARS-CoV-2变种和有限的抗病毒疗效需要新的治疗方法.
  • 反感性寡核酸 (ASO) 提供了针对病毒RNA的潜在策略.

研究的目的:

  • 设计,选和评估针对SARS-CoV-2基因组和亚基因组RNA的反感性寡核酸 (ASO).
  • 确定和验证在体内对抗SARS-CoV-2感染的有效性的主要ASO候选者.
  • 评估SARS-CoV-2变种中ASO目标部位的保存性.

主要方法:

  • 在人类细胞中设计和选针对SARS-CoV-2RNA的ASO,使用基于发光的记者测定和RT-qPCR.
  • 在SARS-CoV-2感染的子中进行了体内验证,这些子接受了鼻内和全身ASO-N1的治疗.
  • 评估临床症状,病毒RNA水平,细胞因子表达和传染性病毒标位.
  • 序列分析以评估跨SARS-CoV-2变种的目标部位保护.

主要成果:

  • ASO-N1被选为主要候选者,其向核体RNA.
  • 对于仓鼠的ASO-N1治疗显著改善了临床症状,减轻了体重减轻,增加了食物消耗.
  • 在鼻腔粘膜中持续减少病毒RNA和炎症性细胞因子,并观察到传染性病毒标位下降.
  • 优化ASO-N1化学协同增强了体外抗病毒疗效.
  • 在四年内,ASO-N1目标部位在主要的SARS-CoV-2变体中得到保护.

结论:

  • 核体RNA向的反感性寡核化物代表了对抗SARS-CoV-2的有希望和强大的抗病毒策略.
  • ASO-N1在体内显示出显著的疗效,并有可能对SARS-CoV-2变种具有广泛的适用性.